{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:06:10Z","timestamp":1762430770363},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.juro.2013.05.059","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T16:36:42Z","timestamp":1369931802000},"page":"2026-2032","source":"Crossref","is-referenced-by-count":20,"title":["Characterization of Ciprofloxacin Resistant Escherichia coli Isolates among Men Undergoing Evaluation for Transrectal Ultrasound Guided Prostate Biopsy"],"prefix":"10.1097","volume":"190","author":[{"given":"Chao","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Clinical Microbiology Laboratory, Northwestern Memorial Hospital, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Malczynski","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Northwestern Memorial Hospital, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Barajas","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Northwestern Memorial Hospital, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Nadler","sequence":"additional","affiliation":[{"name":"Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"Scheetz","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois"},{"name":"Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa R.","family":"Zembower","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.05.059_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)38663-9","article-title":"Ultrasound guided transrectal core biopsies of the palpably abnormal prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrurol.2011.153","article-title":"Infection: prostate biopsy-infection and prior fluoroquinolone exposure","volume":"8","author":"Liss","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after\u00a0transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib4","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0090-4295(98)00296-9","article-title":"Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy","volume":"52","author":"Kapoor","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.05.059_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","article-title":"Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study","volume":"85","author":"Aron","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.05.059_bib7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib8","first-page":"CD006576","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","volume":"5","author":"Zani","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.juro.2013.05.059_bib9","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.juro.2013.05.059_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-5347(17)53860-4","article-title":"Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy","volume":"127","author":"Crawford","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The\u00a0incidence of fluoroquinolone resistant infections after prostate biopsy\u2013are fluoroquinolones still effective prophylaxis?","volume":"179","author":"Feliciano","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.urology.2010.12.067","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment","volume":"77","author":"Zaytoun","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.05.059_bib13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1464-410X.2010.09416.x","article-title":"Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?","volume":"106","author":"Hori","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.05.059_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","article-title":"Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy\u2013should we reassess our practices for antibiotic prophylaxis?","volume":"18","author":"Steensels","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.juro.2013.05.059_bib16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.059_bib17","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Second Informational Supplement","year":"2012"},{"key":"10.1016\/j.juro.2013.05.059_bib18","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A7","year":"2006"},{"key":"10.1016\/j.juro.2013.05.059_bib19","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.46.12.4035-4037.2002","article-title":"Promoters P3, Pa\/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance","volume":"46","author":"Lartigue","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.juro.2013.05.059_bib20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1128\/JCM.01877-07","article-title":"Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007","volume":"46","author":"Qi","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.juro.2013.05.059_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1464-410X.2010.09294.x","article-title":"Prevalence of\u00a0antimicrobial resistance in intestinal flora of\u00a0patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy","volume":"106","author":"Batura","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.05.059_bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/JCM.01885-10","article-title":"Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy","volume":"49","author":"Liss","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.juro.2013.05.059_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2011.09.057","article-title":"Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates","volume":"79","author":"Duplessis","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.05.059_bib24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/cis194","article-title":"Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen","volume":"54","author":"Williamson","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2013.05.059_bib25","doi-asserted-by":"crossref","unstructured":"Liss MA, Peterson EM, Johnston B et\u00a0al: Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology 81: 548.","DOI":"10.1016\/j.urology.2012.10.056"},{"key":"10.1016\/j.juro.2013.05.059_bib26","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2013.05.059_bib27","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.45.8.2378-2380.2001","article-title":"Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region","volume":"45","author":"Friedman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.juro.2013.05.059_bib28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.juro.2013.05.059_bib29","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/AAC.45.7.1994-2000.2001","article-title":"Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87)","volume":"45","author":"Barnard","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.juro.2013.05.059_bib30","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713044248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713044248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.05.059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:32:39Z","timestamp":1651203159000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.05.059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1016\/j.juro.2013.05.059"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.05.059","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}